GlassScriptPhysician profile
Leigh Brooks
NPI 1003299116
$75,457.50
in general payments reported to CMS, 2019-2025
25 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,396 · 2022: $18K · 2023: $25K · 2024: $18K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Travel and Lodging: $18K · Consulting Fee: $11K · Food and Beverage: $6,094 · Education: $14.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,792.00 |
| Travel and Lodging | $17,712.73 |
| Consulting Fee | $10,667.50 |
| Food and Beverage | $6,094.15 |
| Education | $14.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $43,212.81 | 2022-2025 | Epclusa |
| Abbvie INC. | $30,798.59 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $247.21 | 2021-2025 | Jardiance, Tradjenta, Synjardy |
| Indivior INC. | $173.54 | 2022-2025 | Sublocade |
| Exact Sciences Corporation | $128.67 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $124.52 | 2021-2025 | Mounjaro, Trulicity, Emgality |
| Alkermes, INC. | $110.55 | 2023-2025 | Vivitrol, Vivitrol |
| Braeburn INC. | $102.28 | 2023-2024 | Brixadi |
| Dexcom, INC. | $98.28 | 2021-2024 | Dexcom G6 Transmitter |
| Amgen INC. | $78.61 | 2021-2025 | Prolia, Evenity |
| Novo Nordisk INC | $59.23 | 2021-2025 | Ozempic, Rybelsus |
| Viiv Healthcare Company | $46.37 | 2023-2024 | Apretude |
| Phathom Pharmaceuticals, INC. | $39.48 | 2024 | Voquezna |
| Novartis Pharmaceuticals Corporation | $35.40 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $32.44 | 2021-2024 | Airsupra |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22.37 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $20.79 | 2021 | |
| Shield Therapeutics INC | $18.70 | 2024 | |
| Idorsia Pharmaceuticals US INC | $18.38 | 2023 | Quviviq |
| Hologic Sales and Service, LLC | $16.12 | 2022 | |
| Glaxosmithkline, LLC. | $16.08 | 2021 | |
| Insulet Corporation | $15.16 | 2024 | Omnipod |
| Pfizer INC. | $14.85 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.26 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leigh Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.